Search results for "AMA"

showing 10 items of 8558 documents

Metabolic changes in the rat liver during pregnancy

1983

During pregnancy the rat liver shows alterations in metabolism which apparently do not to occur in the non-pregnant animal. In our study, the following metabolite concentrations and enzyme activities in the liver of pregnant and non-pregnant rats were measured after fasting periods of 6 and 12 h: malate, fumarate, isocitrate, alpha-keto-glutarate, glutamate, malate-dehydrogenase, fumarate-hydratase, glutamate-dehydrogenase, isocitrate-dehydrogenase, aspartate-aminotransferase and after 12 h fast, the concentrations of acetyl coenzyme A and citrate. These results are discussed with regard to their possible importance for the maternal and fetal energy supply.

medicine.medical_specialtyMetaboliteCitric Acid Cyclechemistry.chemical_compoundPregnancyInternal medicinemedicineAnimalschemistry.chemical_classificationFetusPregnancybusiness.industryGlutamate receptorTricarboxylic AcidsObstetrics and GynecologyFastingGeneral MedicineMetabolismmedicine.diseaseRatsCitric acid cycleEnzymeEndocrinologyLiverchemistryGestationFemalebusinessArchives of Gynecology
researchProduct

A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14Mb microduplication in region 19q12

2011

A 9-year-old girl born to healthy parents showed manifestations suggestive of ataxia telangiectasia (AT), such as short stature, sudden short bouts of horizontal and rotary nystagmus, a weak and dysarthric voice, rolling gait, unstable posture, and atactic movements. She did not show several cardinal features typical of AT such as frequent, severe infections of the respiratory tract. In contrast, she showed symptoms not generally related to AT, including microcephaly, profound motor and mental retardation, small hands and feet, severely and progressively reduced muscle tone with slackly protruding abdomen and undue drooling, excess fat on her upper arms, and severe oligoarthritis. A cranial…

medicine.medical_specialtyMicrocephalyPathologyCell Cycle ProteinsAtaxia Telangiectasia Mutated ProteinsProtein Serine-Threonine KinasesBiologyShort statureAtaxia Telangiectasia Mutated ProteinsAtaxia TelangiectasiaInternal medicineChromosome DuplicationGene duplicationGeneticsmedicineHumansLymphocytesChildSalivaCerebellar hypoplasiaMetaphaseGenetics (clinical)Mental DisordersTumor Suppressor ProteinsGeneral Medicinemedicine.diseaseDNA-Binding ProteinsEndocrinologyChromosome InversionAtaxia-telangiectasiaChromosomal regionSpeech delayMicrocephalyFemalemedicine.symptomApoptosis Regulatory ProteinsChromosomes Human Pair 19DNA DamageEuropean Journal of Medical Genetics
researchProduct

New approaches in the treatment of Adamantiades-Behçet's disease.

2005

Purpose of review To update clinicians on the recent advances in the treatment of Adamantiades-Behcet's disease. Recent findings Interferon-α-2a and infliximab have proved able to induce prompt remission in the vast majority of Adamantiades-Behcet's patients with DMARD-resistant uveoretinitis. Efficacy of interferon-α-2a has also been reported for mucocutaneous lesions, arthritis, and (more anecdotally) for neuro-Behcet, while results from small case series suggest that infliximab is beneficial for mucocutaneous lesions and (more anecdotally) for arthritis and gastro-intestinal manifestations. Two cases of neuro-Behcet treated with infliximab showed a complete resolution. Finally, in a rand…

medicine.medical_specialtyMucocutaneous zoneArthritisBehcet's diseaseDiseaseInterferon alpha-2Receptors Tumor Necrosis Factorlaw.inventionEtanerceptEtanerceptRheumatologyRandomized controlled triallawAntibodies Monoclonal; Behcet Syndrome; Chaperonin 60; Humans; Immunoglobulin G; Immunologic Factors; Interferon-alpha; Receptors Tumor Necrosis Factor; Recombinant ProteinsmedicineHumansImmunologic FactorsIFN-α2abusiness.industryBehcet SyndromeAntibodies MonoclonalInterferon-alphaChaperonin 60medicine.diseaseDermatologyeye diseasesInfliximabAdamantiades-Behçet's diseaseInfliximabRecombinant Proteinsstomatognathic diseasesImmunoglobulin GImmunologyTumour necrosis factorbusinessTolerizationUveitismedicine.drugCurrent opinion in rheumatology
researchProduct

Clinical and histopathological study of the oral multifocal melanoacanthoma : a case report

2019

Melanoacanthoma is a blackened mucocutaneous lesion, mainly affecting individuals with dark skin and exhibiting rapid development. Differential diagnosis includes nevus, amalgam tattoo and melanoma. This article reports a case of a 53-year-old white woman, who exhibited multiple blackened lesions on the gingiva and upper lip. After incisional biopsy, the presence of numerous melanin-containing dendritic cells distributed throughout the epithelial thickness, which were S-100 (+), were observed microscopically. Final diagnosis was multifocal oral melanoacanthoma. Follow-up for 28 months has shown appearing of more lesions in gingiva and upper lip. Therefore, the importance of differential dia…

medicine.medical_specialtyMucocutaneous zoneCase Report030209 endocrinology & metabolismLesion03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineNevusOral mucosaGeneral DentistryOral Medicine and Pathologybusiness.industryMelanomaAmalgam tattoo030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyMelanoacanthomastomatognathic diseasesmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASmedicine.symptomDifferential diagnosisbusiness
researchProduct

Cardiac complications in thalassemia: noninvasive detection methods and new directions in the clinical management.

2004

The natural history of thalassemia has shown substantial change during these years. This applies for each aspect of the pathology (for example, endocrinological, hepatological and psychological) and also for the pathology that has presented and still presents the main cause of death: myocardial dysfunction. In this review, the pathophysiology of cardiac complications, possible role of myocarditis, new knowledge on pathogenesis, and noninvasive detection methods for iron overload in the heart are pointed out. Prophylaxis of cardiomyopathy and new therapy strategies of myocardial dysfunction, including the impact of the new chelation treatment, are discussed.

medicine.medical_specialtyMyocarditisThalassemiaCardiomyopathychemistry.chemical_compoundInternal medicineInternal MedicineMedicineHumansCause of deathbusiness.industryGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPathophysiologyNatural historychemistryEchocardiographyCardiologyThalassemiaCardiac complications in thalassemiaCardiology and Cardiovascular MedicinebusinessDeferiproneCardiomyopathiesHeart damage
researchProduct

Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity

1998

Here we investigated the possible regulation of neurosteroidogenesis by N-methyl-D-aspartic acid (NMDA) receptor activation and addressed the hypothesis that neurosteroid synthesis may be involved in acute excitotoxicity. In the isolated retina, exposure to NMDA modified pregnenolone and pregnenolone sulphate formation. This effect was dose and time dependent, the synthesis being increased by relatively moderate NMDA doses (1-100 microM) within 30 min exposure and reduced to its control value by 60 min or by raising drug concentrations. NMDA-stimulated neurosteroid synthesis was blocked by (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate (MK-801) and 3(2-ca…

medicine.medical_specialtyNeuroactive steroidChemistryGABAA receptorGeneral NeuroscienceExcitotoxicityGlutamate receptorBicucullinemedicine.disease_causechemistry.chemical_compoundEndocrinologynervous systemMuscimolInternal medicinemedicinePregnenoloneNMDA receptormedicine.drugEuropean Journal of Neuroscience
researchProduct

Post-acute COVID-19 neurological syndrome: A new medical challenge

2021

In December 2019, in Wuhan (China), a highly pathogenic coronavirus, named SARS-CoV-2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly spreading around the world, hence it provoked the COVID-19 pandemic. This emergency launched by SARS-CoV-2 also had, and still has, devastating socio-economic aspects. Assessing the impact of COVID-19 on vulnerable groups of people is crucial for the adaptation of governments’ responses. Growing scientific evidence suggests that it is essential to keep the attention on people after acute SARS-CoV-2 infection; indeed, some clinical manifestations are frequently present even after recovery. There is consensus on the need to defi…

medicine.medical_specialtyNeurologyCoronavirus disease 2019 (COVID-19)Brain damage COVID-19 Neurology Post-scute COVID-19 neurological syndrome SARS-CoV-2Brain damageReviewScientific evidence03 medical and health sciences0302 clinical medicinePandemicmedicine030212 general & internal medicineIntensive care medicineStrokebusiness.industrySARS-CoV-2neurologyRCOVID-19General Medicinebrain damagemedicine.diseasepost-scute COVID-19 neurological syndromeDeliriumMedicinemedicine.symptombusinessPneumonia (non-human)030217 neurology & neurosurgery
researchProduct

Practical importance of neuroprotection in Parkinson's disease.

2003

Consensus could be reached that there is overwhelming evidence of preclinical neuroprotection. However, the evidence of neuroprotection/neurorescue under clinical conditions is limited. Lessons from clinical trials designed to show neuroprotection (selegiline, amantadine, dopamine agonists) demonstrate that with the drugs available neuroprotection/neurorescue has to start as early as possible. A PET-controlled clinical trial with ropinirole shows that there seems to be a good chance for neuroprotection in the early phase of Parkinson's disease in patients treated from the very beginning of the disease while there is no such benefit in patients with a late start of a neuroprotective therapeu…

medicine.medical_specialtyNeurologyParkinson's diseaseIndolesBioinformaticsNeuroprotectionAntiparkinson AgentsDegenerative diseaseSelegilineAmantadineMedicineHumansbusiness.industrySelegilineAmantadineParkinson Diseasemedicine.diseaseClinical trialRopiniroleNeuroprotective AgentsNeurologyDopamine AgonistsNeurology (clinical)businessNeurosciencemedicine.drugJournal of neurology
researchProduct

Changes in glutamatergic neurotransmission within the migraine cycle

2013

Background Although some neurophysiological studies have showed cortical excitability changes during different phases of the migraine cycle, the pathophysiological mechanisms underlying attacks recurrence remain unknown. Here we evaluated the response of the migraine motor-cortex to brief trains of 5-Hz repetitive transcranial magnetic stimulation (rTMS) in order to study, indirectly, presynaptic mechanisms of glutamatergic neurotransmission across the different phases of the migraine cycle.

medicine.medical_specialtyNeurologybusiness.industrymedicine.medical_treatmentClinical NeurologyGeneral MedicineNeurotransmissionNeurophysiologymedicine.diseaseTranscranial magnetic stimulationGlutamatergicAnesthesiology and Pain MedicineMigrainePoster PresentationmedicineNeurology (clinical)businessNeuroscienceThe Journal of Headache and Pain
researchProduct

Dietary intake of nutrients of great interest in immunonutrition to prevent muscle damage in soccer players

2008

Soccer is a sport in which players are exposed to long-term periods of training and players need to augment strength and fat-free massgains by resistance training, minimize muscle damage and soreness and help to improve endurance. Recently, the incidence of injuries hasincreased during and preceding soccer matches, which inuences the effectiveness of the team. One study

medicine.medical_specialtyNutrition and Dieteticsbusiness.industryIncidence (epidemiology)Dietary intakeeducationResistance trainingMedicine (miscellaneous)Muscle damageNutrientPhysical therapymedicineAugmentbusinesshuman activitiesProceedings of the Nutrition Society
researchProduct